In the current study, we found that serum IGF-2 levels were significantly lower in BD patients with depressive episode, which is consistent with the change in MDD, while no association of IGF-2 levels with HAMD-17 scores was found in these patients. This evidence concerns the gene IGF2 and major depressive disorder.